These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6011765)

  • 21. [Adverse effect of phthivazid in the treatment of children with tuberculosis].
    Galaev VS
    Pediatriia; 1987; (6):90-1. PubMed ID: 3498930
    [No Abstract]   [Full Text] [Related]  

  • 22. Resistance of Mycobacterium tuberculosis to antituberculosis drugs in the Central Region of Thailand, 1996.
    Riantawan P; Punnotok J; Chaisuksuwan R; Pransujarit V
    Int J Tuberc Lung Dis; 1998 Aug; 2(8):616-20. PubMed ID: 9712274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug resistance among tuberculosis patients, New York City, 1991 and 1992.
    Driver CR; Frieden TR; Bloch AB; Onorato IM
    Public Health Rep; 1994; 109(5):632-6. PubMed ID: 7938383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Problems of primary resistance].
    Danzer W
    Beitr Klin Erforsch Tuberk Lungenkr; 1968; 138(1):48-50. PubMed ID: 5728645
    [No Abstract]   [Full Text] [Related]  

  • 25. [The efficacy of treatment of diffuse infiltrative-pneumonic pulmonary tuberculosis].
    Pervova TN; Polevikt GK
    Probl Tuberk; 1966; 44(4):10-5. PubMed ID: 6011830
    [No Abstract]   [Full Text] [Related]  

  • 26. [Resistance of Mycobacterium tuberculosis in Ferrol, Spain. Associated factors].
    García Rodríguez JF; Mariño Callejo A; Lorenzo García MV; Rodríguez Mayo M; Domínguez Gómez D; Sesma Sánchez P
    Med Clin (Barc); 1999 Nov; 113(15):572-4. PubMed ID: 10605682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug resistance pulmonary tuberculosis in the Eastern Province of Saudi Arabia.
    Al-Rubaish AM; Madania AA; Al-Muhanna FA
    Saudi Med J; 2001 Sep; 22(9):776-9. PubMed ID: 11590451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Primary resistance to isoniazid (author's transl)].
    Jungbluth H; Bürger B
    Prax Klin Pneumol; 1979 Nov; 33(11):1106-8. PubMed ID: 523420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic effects of treatment with RFP on previously treated cases of pulmonary tuberculosis (author's transl)].
    Sakurai H; Watanabe Y; Yamanaka M; Moriguchi T; Fujii K; Uenoyama T
    Kekkaku; 1980 Nov; 55(11):485-91. PubMed ID: 6780716
    [No Abstract]   [Full Text] [Related]  

  • 30. [Initial resistance to streptomycin, isoniazid, rifampicin and ethambutol in bacillus-laden tuberculosis patients at the National Center of Pneumo-physiology at Cotonou (Benin)].
    Anagonou SY; Gninafon M; Josse R; Kinde-Gazard D; Tawo L; Foundohou J
    Bull Soc Pathol Exot; 1993; 86(2):144-7. PubMed ID: 8353477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inactivation of tubazid and its influence on the effectiveness of antibacterial therapy of patients with pulmonary tuberculosis].
    Sumbatov GA; Ioffe RA; Poliakova SG
    Probl Tuberk; 1965; 43(8):23-8. PubMed ID: 5869065
    [No Abstract]   [Full Text] [Related]  

  • 32. Value of isoniazid-thiacetazone combination in unsupervised ambulatory cases of pulmonary tuberculosis.
    Narang RK
    Indian Pract; 1967 Jul; 20(7):465-8. PubMed ID: 4169024
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical significance of the inactivation of tubazid in the endobronchial method of treatment of destructive pulmonary tuberculosis].
    Kanevskaia SS; Rzhavskov IuV
    Probl Tuberk; 1967; 45(10):44-8. PubMed ID: 5617546
    [No Abstract]   [Full Text] [Related]  

  • 34. A continuing survey of drug-resistant tuberculosis, New York City, April 1994.
    Fujiwara PI; Cook SV; Rutherford CM; Crawford JT; Glickman SE; Kreiswirth BN; Sachdev PS; Osahan SS; Ebrahimzadeh A; Frieden TR
    Arch Intern Med; 1997 Mar; 157(5):531-6. PubMed ID: 9066457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Efficiency of chemotherapy of destructive pulmonary tuberculosis, based on the results of rapid detection of drug sensitivity to isoniazid and rifampicin with the "TB-Biochip" test system].
    Kuz'min AV; Vasil'eva IA; Chernousova LN
    Probl Tuberk Bolezn Legk; 2006; (8):17-23. PubMed ID: 17002052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML; Iuditskiĭ MV; Semenova OV
    Probl Tuberk Bolezn Legk; 2004; (3):26-8. PubMed ID: 15338896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug resistance in initial isolates of Mycobacterium tuberculosis in England and Wales, 1982-1991.
    Warburton AR; Jenkins PA; Waight PA; Watson JM
    Commun Dis Rep CDR Rev; 1993 Dec; 3(13):R175-9. PubMed ID: 7507770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Blood bacteriostatic activity in patients with respiratory tuberculosis].
    Manicheva OA; Vishnevskiĭ BI; Ivanova LI; Pavlova MV; Archakova LI
    Probl Tuberk; 2001; (8):24-6. PubMed ID: 11767384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tuberculosis and its control: lessons to be learned from past experience, and implications for leprosy control programmes.
    Styblo K
    Ethiop Med J; 1983 Apr; 21(2):101-22. PubMed ID: 6852000
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug treatment of tuberculosis.
    Steiner M
    N Y State J Med; 1984 Jun; 84(6):294-5. PubMed ID: 6589508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.